Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

914 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 914 results

Early research (Phase 1)Study completedNCT00978900
What this trial is testing

Effects of Artificial Sweetener on Gastrointestinal (GI) Peptide Secretion

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 12
Not applicableUnknownNCT04232605
What this trial is testing

Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in Humans

Who this might be right for
Headache, Migraine
Danish Headache Center 43
Large-scale testing (Phase 3)UnknownNCT02718950
What this trial is testing

Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans

Who this might be right for
ObesityType 2 Diabetes Mellitus
University of Campinas, Brazil 20
Large-scale testing (Phase 3)Study completedNCT01607450
What this trial is testing

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Who this might be right for
Type 2 Diabetes MellitusHealthy
Indiana University 33
Not applicableStudy completedNCT05177653
What this trial is testing

Separate and Combined Extrapancreatic Effects of the Incretin Hormones

Who this might be right for
Pancreatectomy; Hyperglycemia
University Hospital, Gentofte, Copenhagen 13
Post-approval studies (Phase 4)Study completedNCT02686177
What this trial is testing

Effect of GLP-1 on Angiogenesis

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 50
Post-approval studies (Phase 4)Study completedNCT02340247
What this trial is testing

Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass

Who this might be right for
Severe Obesity
Hvidovre University Hospital 11
Not applicableLooking for participantsNCT07042672
What this trial is testing

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

Who this might be right for
Binge Eating Disorder Associated With ObesityBinge Eating DisorderEating Disorder Binge+4 more
Haukeland University Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT05254314
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Who this might be right for
Asthma
Vanderbilt University Medical Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT06411210
What this trial is testing

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

Who this might be right for
Diabetes type1Obesity
Yale University 54
Testing effectiveness (Phase 2)WithdrawnNCT03371862
What this trial is testing

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

Who this might be right for
Short Bowel Syndrome
Imperial College London
Not applicableStudy completedNCT00834938
What this trial is testing

Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

Who this might be right for
DiabetesBariatric SurgeryObesity
University of Campinas, Brazil 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06987513
What this trial is testing

RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Who this might be right for
Alcohol Use Disorder (AUD)
Altimmune, Inc. 100
Large-scale testing (Phase 3)Study completedNCT01558271
What this trial is testing

LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 492
Not applicableStudy completedNCT03129594
What this trial is testing

Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction

Who this might be right for
Coronary AngiographyGlucagon-like Peptide-1
Chinese PLA General Hospital 709
Early research (Phase 1)Ended earlyNCT05668936
What this trial is testing

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Who this might be right for
Non-alcoholic Steatohepatitis
AstraZeneca 31
Large-scale testing (Phase 3)Study completedNCT03480022
What this trial is testing

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

Who this might be right for
Pre DiabetesPolycystic Ovary SyndromeObesity Android
Woman's 88
Not applicableStudy completedNCT02895672
What this trial is testing

GLP-1/Basal Insulin Combination Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Albany College of Pharmacy and Health Sciences 150
Post-approval studies (Phase 4)Study completedNCT01755572
What this trial is testing

Blood Pressure Outcomes With Liraglutide Therapy

Who this might be right for
Type 2 DiabetesSystolic Hypertension
Mount Sinai Hospital, Canada 22
Large-scale testing (Phase 3)Study completedNCT05205928
What this trial is testing

Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care

Who this might be right for
Type 1 DiabetesDiabetes Mellitus, Type 1
McGill University Health Centre/Research Institute of the McGill University Health Centre 28
Load More Results